SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026)
Clinical and Translational Oncology · 27.07.2026
DOI: 10.1007/s12094-026-04520-4 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical and Translational Oncology, online erschienen am 27.07.2026. Verfasst von Nuria Rodriguez Salas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital La Paz, Madrid, Spain. nuria.rodriguez@salud.madrid.org. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sociedad Española de Oncología Médica.
Abstract (Originalsprache)
Identification of molecular alterations in cancer and advances in technology have enhanced the use of molecular alterations for the diagnosis and treatment of cancer in routine clinical practice. Multi-determination platforms are now available in most Spanish hospitals. First developed in 2021, the objective of these clinical practice guidelines is to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice. Here, we provide updated guidelines, which include the most recent advancements in this area.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Hospital La Paz, Madrid, Spain. nuria.rodriguez@salud.madrid.org.
- Department of Medical Oncology, Hospital Universitario Reina Sofia, Instituto Maimonides de Investigacion Biomedica, Universidad de Córdoba, Córdoba, Spain.
- Department of Medical Oncology, Hospital General Universitario, Ciudad Real, Spain.
- Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
- Department of Medical Oncology, Hospital Marina Baixa de Villajoyosa, Alicante, Spain.
- Department of Medical Oncology, Hospital Universitario Nuestra Señora de La Candelaria, Tenerife, Spain.
Förderung
- Sociedad Española de Oncología Médica
Zitieren
APA
Rodriguez Salas, N., de la Haba-Rodriguez, J., Ferragut Lloret, F., Vaz Salgado, M. A., Oré Arce, M., Cardeña Gutiérrez, A., Beato Zambrano, C., Rodríguez Alonso, R. M., López López, R., & García-Donas Jiménez, J. (2026). SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026). Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04520-4
Vancouver
Rodriguez Salas N, de la Haba-Rodriguez J, Ferragut Lloret F, Vaz Salgado MA, Oré Arce M, Cardeña Gutiérrez A, et al. SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026). Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04520-4
BibTeX
@article{RodriguezSalas2026,
author = {Rodriguez Salas, Nuria and de la Haba-Rodriguez, Juan and Ferragut Lloret, Ferran and Vaz Salgado, Maria Angeles and Oré Arce, Martín and Cardeña Gutiérrez, Ana and Beato Zambrano, Carmen and Rodríguez Alonso, Rosa María and López López, Rafael and García-Donas Jiménez, Jesús},
title = {SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026)},
journal = {Clinical and Translational Oncology},
year = {2026},
doi = {10.1007/s12094-026-04520-4}
}
EUVIMED